The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tomisaku Kawasaki, Pediatrician Who Discovered Disease That Bears His Name, Dies at 95

Tomisaku Kawasaki, Pediatrician Who Discovered Disease That Bears His Name, Dies at 95

June 18, 2020 • By Renée Bacher

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Kawasaki

Dr. Kawasaki

Japanese pediatrician Tomisaku Kawasaki, MD, who identified an inflammatory syndrome that affects children, died on June 5 in Tokyo. He was 95.

You Might Also Like
  • Doctors Detail Kawasaki-Like Disease in Adult COVID-19 Patients
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
  • Kawasaki Disease Spread May be Linked to Wind
Explore This Issue
August 2020
Also By This Author
  • Yes, the FDA Employs Rheumatologists. Here’s Their Role.

Tenacity & Attention to Detail
Born Feb. 7, 1925, in Tokyo, Dr. Kawasaki graduated from medical school at what is now Chiba University in Chiba, Japan, in 1948 and worked as staff pediatrician at the Red Cross Hospital in suburban Tokyo. It was there in 1961 that he saw his first patient with the disease that would eventually bear his name. Kawasaki disease has been in the news recently because some children testing positive for COVID-19 have exhibited comparable symptoms, including rash and extremely bloodshot eyes. “The connection between [the conditions] is a wide open question right now,” says pediatrician Jane Burns, MD, director of the Kawasaki Disease Research Center at the University of California, San Diego.

Dr. Kawasaki with Dr. Burns

Dr. Kawasaki with Dr. Burns

Dr. Kawasaki’s patient was a 4-year-old patient with unusual symptoms he could not diagnose. “The boy presented with a fever, congestion of the mucous membranes, cervical lymphadenopathy and desquamation,” says Philip Seo, MD, MHS, associate professor of medicine at the Johns Hopkins University School of Medicine, Baltimore, director of both the Johns Hopkins Vasculitis Center and the Johns Hopkins Rheumatology Fellowship Program, and physician editor of The Rheumatologist. “The patient eventually improved on his own and was discharged with the honest label of ‘diagnosis unknown.’”

Dr. Kawasaki subsequently had seven more patients with these unusual symptoms, which he documented in great detail and presented as a case series at a meeting of the Japanese Pediatric Association. When he submitted the series for publication, it was rejected; the reviewers suggested he had observed an atypical form of Stevens-Johnson syndrome.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“There was almost an idea that because he was outside of the establishment, he could not possibly have described a new disease,” says Dr. Burns, who first met Dr. Kawasaki when she was a young infectious disease fellow and over the years came to consider him a dear friend.

During the next six years Dr. Kawasaki documented 50 similar cases of children with symptoms that included high fevers, extremely red eyes and lips, and a swollen red tongue, as well as swollen, peeling hands and feet. This case series was published.

“Maybe because he was unfettered by too much training, he could just see clearly what was in front of him,” says Dr. Burns. “Can you imagine today a rheumatologist waiting to report a new condition and gathering 50 patients over a period of years?”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Professional Topics, Profiles Tagged With: Kawasaki, Kawasaki disease, Tomisaku KawasakiIssue: August 2020

You Might Also Like:
  • Doctors Detail Kawasaki-Like Disease in Adult COVID-19 Patients
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
  • Kawasaki Disease Spread May be Linked to Wind
  • Gene Expression Signature Useful for Diagnosing Kawasaki Disease

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)